Source: ScienceNOW Daily News
Posted: June 6, 2006
Summary:
Harvard University researchers have been given the go-ahead to use cloning to create disease-specific lines of human embryonic stem cells.
Experts say research cloning--known as somatic cell nuclear transfer (SCNT)--will give scientists a far more effective tool for studying diseases such as diabetes and Parkinson's. But some people oppose the technique for religious and philosophical reasons because it involves creating and destroying fertilized eggs, and the procedure is banned in some states.
Commentary: This story gives a clear overview of the procedure and arrangement of these new experiments.
No comments:
Post a Comment